Systemic lupus erythematosus after heavy exposure to quartz dust in uranium mines: Clinical and serological characteristics

Lupus

Volumn 5, Issue 1, 1996, Pages 62-69

  Conrad, K ^a   Mehlhorn, J ^a   Luthke K ^a   Dorner T ^a   Frank, K H ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Autoantibodies; Silica exposure; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; SILICON DIOXIDE;

ADULT; AGED; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DUST EXPOSURE; HUMAN; MALE; OCCUPATIONAL EXPOSURE; PHOTOSENSITIVITY; PRIORITY JOURNAL; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; URANIUM MINE;

EID: 0030030988     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500112     Document Type: Article

References (34)

1. Mehlhorn J. Quarzkristalle in der Haut als Auslöser der Sklerodermie - Teil I. Dt. Dermatologe 1992; 11: 1563-72.
2. Shoenfeld Y, Isenberg D. The mosaic of autoimmunity (The factors associated with autoimmune diseases). Amsterdam New York Oxford: Elsevier, 1990.
3. Ebihara I, Kawami M. Health hazards of mineral dust with special reference to the causation of immunopathologic systemic disease. J Sci Labour 1985; 61: 1-33.
4. Ziegler V, Haustein UF. Die progressive Sklerodermie - eine quarzinduzierte Berufskrankheit? Dermatol Mon schr 1992; 178: 34-43.
5. Bramwell B. Diffuse scleroderma - it's frequency, it's occurrence in stone-masons, it's treatment by fibrinolysin - elevations of temperature due to fibrinolysin injections. Edinburgh Med J 1914; 12: 387-401.
6. Erasmus LD. Scleroderma in gold-miners on the Witwatersrand with particular reference to pulmonary manifestations. S Afric J Lab Clin Med 1957; 3: 209-31.
7. Rodnan GP, Benedek TG, Medsger TA, Cammarata RJ. The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumo coniosis and other forms of silicosis. Ann Intern Med 1967, 66: 323-34.
8. Baur X, Altmeyer P, Degens P et al. Systemic sclerosis in German uranium miners under special consideration of genetic predisposition risk factors. (Submitted for publication).
9. Bernardini PI, Iannaccone A. Silicosi polmonare associata a lupus eritematoso sistemico. Lav Um 1982; 30: 8-16.
10. Hatron PY, Plouvier B, Francois M, Baclet JL, Deconning P, Devulder B. Association lupus erythemateux et silicose. Rev Med Int 1982; 3: 245-6.
11. Cledes J, Herve JP, Clavier J, Youinou P, Ollivier JP. Silicose pulmonaire et lupus erythemateux dissemine. Poumon Coeur 1983; 39: 205-7.
12. Tan EM, Cohen AS, Fries JF et al. The revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
13. Bauer, H-D, Schulze U. Staub- und Schwermetallbelastung. In: Untersuchungen zur Staub- und Schwermetallbelastung sowie zur Strahlenbelastung durch Radionuklide in Stäuben in der Gang-Erzlagerstätte Schlema-Alberoda der Wismut. Bochum: Bergbau-Berufsgenossenschaft, 1995: 30-88.
14. Vallayathan V, Xianglin S, Dalal NS, Castronova V. Generation of free radicals from freshly fracturated silica dust. Am Rev Respir Dis 1988; 138: 1213-9.
15. Shoenfeld Y, Alarcón-Segovia D. The mosaic of systemic lupus erythematosus: Highlights of the Third International Conference on SLE. Lupus 1992; 1: 269-83.
16. Hopkinson, ND, Doherty M, Powell RJ. Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 1994; 53: 675-80.
17. Sanchez-Roman J, Wichmann I, Salberri J, Varela JM, Nunez-Roldan A. Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann Rheum Dis 1993; 52: 534-8.
18. Bigazzi PE. Autoimmunity and heavy metals. Lupus 1994; 3: 449-53.
19. Yoshida S, Gershwin ME. Autoimmunity and selected environmental factors of disease induction. Semin Arthritis Rheum 1993; 22: 399-419.
20. Czirjak L, Schlammadinger J, Szegedi G. Systemic sclerosis and exposure to Trichloroethylene. Dermantol 1993; 186: 237-8.
21. Urowitz MB, Stevens MB, Shulman LE. The influence of age on the clinical pattern of systemic lupus erythematosus. Arthritis Rheum 1967; 10: 319-20.
22. Ward MM, Polisson RP. A meta-analysis of the clinical manifestation of older-onset systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1226-32.
23. Jonsson H, Nived O, Sturfelt G. The effect of age on clinical and serological manifestation in unselected patients with systemic lupus erythematosus. J Rheumatol 1988; 15: 505-9.
24. Catoggio LJ, Skinner RP, Smith G, Maddison PJ. Systemic lupus erythematosus in the elderly: Clinical and serological characteristics. J Rheumatol 1984; 11: 175-81.
25. Hochberg MC, Boyd RE, Ahearn JM et al. Systemic lupus erythematosus: A review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine 1985; 64: 285-95.
26. Koh ET, Boey ML. Late onset lupus: A clinical and immunological study in a predominantly chinese population. J Rheumatol 1994; 21: 1463-7.
27. Bell DA, Rigby R, Stiller CR, Clark WF, Harth M, Ebers G. HLA antigens in systemic lupus erythematosus: Relationship to disease severity, age at onset, and sex. J Rheumatol 1984; 11: 475-9.
28. Hashimoto H, Tsuda H, Hirano T, Takasaki Y, Matsumoto T, Hirose S. Differences in clinical and immunological findings of systemic lupus erythematosus related to age. J Rheumatol 1987; 14: 497-501.
29. Font J, Cervera R, Navarro M et al. Systemic lupus erythematosus in men: clinical and immunological characteristics. Ann Rheum Dis 1992; 51: 1050-2.
30. Miller MH, Urowitz MB, Gladmann DD. The significance of thrombo cytopenia in systemic lupus erythematosus. Arthritis Rheum 1983; 26: 1181-5.
31. Sthoeger ZM, Geltner D, Rider A, Bentwich Z. Systemic lupus erythematosus in 49 israeli males: a retrospective study. Clin Exp Rheumatol 1987; 5: 233-40.
32. Tramposch HD, Smith CD, Senécal JL, Rothfield NF. A long-term longitudinal study of anticentromere antibodies. Arthritis Rheum 1984; 27: 121-4.
33. Weiner ES, Hildebrandt S, Senécal JL et al. Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. Arthritis Rheum 1991; 34: 68-77.
34. Conrad K, Rihs HP, Mehlhorn J, Jermolow B, Baur X, Frank KH. Humoral autoimmunity, HLA alleles and development of systemic autoimmune diseases in uranium miners exposed to quartz dust. Autoimmunity 1993; 14(suppl 1): 4 (abstract B.6).